 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 October 1993 | Volume 119 Issue 7 Part 2 | Pages 677-680
The purpose of this report is to propose standards for the successful treatment of obesity. This process is somewhat arbitrary because obesity is a multifactorial disease and because standards need revision as diagnostic and treatment techniques improve. Weight loss, the classic standard of success, does not account for individual variability. Reduction in other measures of body size, such as body mass index, percentage of excess weight, and body fat, may be preferable. Improvement in known complications of obesity (diabetes mellitus, hypertension, hyperlipoproteinemia, sleep apnea, and psychosocial problems) are equally valid measures of success. Because obesity is a chronic disease, maintenance of weight loss is included as a standard of success. Response to obesity treatment varies, and thus criteria to define minimal, intermediate, and full success for each variable are necessary.
Author and Article Information
From the Department of Veterans Affairs Medical Center, Hampton, Virginia.
METHODS FOR VOLUNTARY WEIGHT LOSS AND CONTROL: NATIONAL INSTITUTES OF HEALTH TECHNOLOGY ASSESSMENT CONFERENCE
Proposed Standards for Judging the Success of the Treatment of Obesity
Requests for Reprints: Richard L. Atkinson, MD, Medical Research Service, Veterans Affairs Medical Center, Hampton, VA 23667.
Grant Support: In part by funds from the Department of Veterans Affairs and from funds at Eastern Virginia Medical School.
This article has been cited by other articles:
|
|
 |
|
  F. G. McMahon, K. Fujioka, B. N. Singh, C. M. Mendel, E. Rowe, K. Rolston, F. Johnson, and A. D. Mooradian Efficacy and Safety of Sibutramine in Obese White and African American Patients With Hypertension: A 1-Year, Double-blind, Placebo-Controlled, Multicenter Trial Arch Intern Med, July 24, 2000; 160(14): 2185 - 2191. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Bray and F. L. Greenway Current and Potential Drugs for Treatment of Obesity Endocr. Rev., December 1, 1999; 20(6): 805 - 875. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. I. Robison Weight, Health, and Culture: Shifting the Paradigm for Alternative Health Care Complementary Health Practice Review, March 1, 1999; 5(1): 45 - 69. [Abstract] [PDF]
|
|
Article
